WGS Reveals Potential Pitfalls of In Vivo CRISPR Gene Editing

News   May 31, 2017 | Original story from Columbia University Medical Center

 
WGS Reveals Potential Pitfalls of In Vivo CRISPR Gene Editing

Structure of the gene editing enzyme Cas9 interacting with guide RNA and DNA (PDB ID: 4OO8). Source: Gabriel Velez (Mahajan Lab)

 
 
 

RELATED ARTICLES

CRISPR Diagnostics Could Detect Any Disease on a Paper Strip

News

A nucleic acid-detecting diagnostics platform that harnesses the gene editing technology CRISPR was announced today by the newly-launched Mammoth Biosciences, which says the technology could change how we diagnose disease.

READ MORE

Chronic Wasting Disease Didn't Cross Into Primates

News

Chronic wasting disease did not cross the species barrier to infect cynomolgus macaque monkeys during a lengthy investigation exploring risks to humans.

READ MORE

Investigating Inflammasomes Implicated in Diabetic Retinopathy

News

Team of researchers employ mouse model exhibiting diabetic retinopathy symptoms that could lead to future translational research studies.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE